Rubby De La Rosa diagnosed with sprained UCL in elbow, could need surgery

1 Comment

UPDATE: Ugh, just when you thought this season couldn’t get any worse for Dodgers fans.

The Dodgers announced following Monday’s game that Rubby De La Rosa was diagnosed with a sprained UCL in his elbow. Surgery is a possibility for the promising young right-hander.

9:08 PM: Steve Dilbeck of the Los Angeles Times reports that the Dodgers have placed rookie right-hander Rubby De La Rosa on the disabled list with elbow inflammation.

De La Rosa had the shortest start of his brief major league career Sunday against the Diamondbacks, giving up three runs on five hits over four innings.

Called up from the minors in May, the 21-year-old right-hander has a 3.71 ERA and 60/31 K/BB ratio over his first 60 2/3 innings in the big leagues. He is averaging 96.1 mph on his fastball this season, which leads all major-league starters.

The Dodgers aren’t going anywhere this season, so they naturally aren’t going to take any chances here. De La Rosa has already thrown 100 2/3 innings this season between the majors and minors, only 9 2/3 innings short of his previous career-high set last season, so the Dodgers were likely planning to shut him down early even before the injury.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.